Sulforaphane Inhibits the Generation of Amyloid-β Oligomer and Promotes Spatial Learning and Memory in Alzheimer’s Disease (PS1V97L) Transgenic Mice

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2018-03-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3233/JAD-171110PMID 29614663
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulforaphane Promotes Mitochondrial Protection in SH-SY5Y Cells Exposed to Hydrogen Peroxide by an Nrf2-Dependent Mechanism

  2018cited by this paper
• Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

  2017cited by this paper
• Nrf2 signaling pathway: Pivotal roles in inflammation.

  2017cited by this paper
• The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation

  2017cited by this paper
• Toxicity mechanisms of arsenic that are shared with neurodegenerative diseases and cognitive impairment: Role of oxidative stress and inflammatory responses.

  2016cited by this paper
• Emerging amyloid disease-modifying drugs for Alzheimer’s disease

  2016cited by this paper
• Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer’s Disease

  2016cited by this paper
• Sulforaphane exerts its anti-inflammatory effect against amyloid-β peptide via STAT-1 dephosphorylation and activation of Nrf2/HO-1 cascade in human THP-1 macrophages.

  2016cited by this paper
• Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis

  2015cited by this paper
• The antioxidant properties of organosulfur compounds (sulforaphane).

  2015cited by this paper
• Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult.

  2014cited by this paper
• Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer’s disease

  2014cited by this paper
• A Lifespan Observation of a Novel Mouse Model: In Vivo Evidence Supports Aβ Oligomer Hypothesis

  2014cited by this paper
• Targeting the β secretase BACE1 for Alzheimer's disease therapy.

  2014cited by this paper
• Neuroprotective Effects of Sulforaphane on Cholinergic Neurons in Mice with Alzheimer’s Disease-Like Lesions

  2014cited by this paper
• Sulforaphane interaction with amyloid beta 1-40 peptide studied by electrospray ionization mass spectrometry.

  2014cited by this paper
• Brain amyloid-β oligomers in ageing and Alzheimer's disease.

  2013cited by this paper
• The case for soluble Aβ oligomers as a drug target in Alzheimer's disease.

  2013cited by this paper
• γ-Secretase inhibitors and modulators.

  2013cited by this paper
• Sulforaphane as a Potential Protective Phytochemical against Neurodegenerative Diseases

  2013cited by this paper
• Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.

  2012cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• Relationships between the amyloid precursor protein and its various proteolytic fragments and neuronal systems

  2012cited by this paper
• The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.

  2012cited by this paper
• Soluble Aβ Promotes Wild-Type Tau Pathology In Vivo

  2012cited by this paper
• Val97Leu mutant presenilin‐1 induces tau hyperphosphorylation and spatial memory deficit in mice and the underlying mechanisms

  2012cited by this paper
• Soluble Aβ oligomer production and toxicity

  2012cited by this paper
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• [Gamma-secretase inhibitors and modulators].

  2011cited by this paper
• SOD1 (Copper/Zinc Superoxide Dismutase) Deficiency Drives Amyloid β Protein Oligomerization and Memory Loss in Mouse Model of Alzheimer Disease*

  2011cited by this paper
• Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

  2011cited by this paper
• Role of Oxidative Stress in the Progression of Alzheimer's Disease

  2010cited by this paper
• CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice

  2010cited by this paper
• Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

  2010cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.

  2008cited by this paper
• Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

  2008cited by this paper
• The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofibril formation.

  2007cited by this paper
• Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer’s disease

  2007cited by this paper
• Oxidative stress activates a positive feedback between the γ‐ and β‐secretase cleavages of the β‐amyloid precursor protein

  2007cited by this paper
• Formation and stabilization model of the 42-mer Abeta radical: implications for the long-lasting oxidative stress in Alzheimer's disease.

  2005cited by this paper
• Nuclear Factor E2-Related Factor 2-Dependent Antioxidant Response Element Activation by tert-Butylhydroquinone and Sulforaphane Occurring Preferentially in Astrocytes Conditions Neurons against Oxidative Insult

  2004cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper

• Potential Efficacy of Polyphenols and Isothiocyanates in the Management of Genitourinary Diseases: A Systematic Review of Preclinical and Clinical Studies.

  2026cites this paper
• Value of Diet and Nutraceuticals in the Prevention and Treatment of Mixed Alzheimer’s Disease and Vascular Dementia

  2026cites this paper
• Role of inflammatory response in benzo[a]pyrene-induced noradrenergic axon degeneration in mouse brain.

  2025cites this paper
• Perspectives on Alzheimer’s Disease Treatment Based on Counteracting Oxidative Stress

  2025cites this paper
• Broccoli for the brain: a review of the neuroprotective mechanisms of sulforaphane

  2025cites this paper
• Glucosinolate Metabolites and Brain Health: An Updated Review on Their Potential Benefits in Neurodegenerative, Neurodevelopmental, and Psychiatric Disorders

  2025cites this paper
• Nutritional strategies against dementia in rural populations

  2025cites this paper
• Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy

  2025cites this paper
• Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders

  2025cites this paper
• Pathway-based network medicine identifies novel natural products for Alzheimer’s disease

  2025cites this paper
• Sulforaphane: An emerging star in neuroprotection and neurological disease prevention.

  2025cites this paper
• Sulforaphane prevents cognitive decline and mitochondrial failure induced by hippocampal expression of caspase-3 cleaved tau.

  2025cites this paper
• The Role of the AMY1 Receptor Signaling Cascade in the Protective Effect of Sulforaphane Against Nitroglycerin‐Induced Migraine in Mice

  2025cites this paper
• In Vitro and In Vivo Insights into a Broccoli Byproduct as a Healthy Ingredient for the Management of Alzheimer’s Disease and Aging through Redox Biology

  2024cites this paper
• Sulforaphane—A Compound with Potential Health Benefits for Disease Prevention and Treatment: Insights from Pharmacological and Toxicological Experimental Studies

  2024cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Current understanding and future directions of cruciferous vegetables and their phytochemicals to combat neurological diseases

  2024cites this paper
• Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases

  2024cites this paper
• Bioactivated Glucoraphanin Improves Cell Survival, Upregulating Phospho-AKT, and Modulates Genes Involved in DNA Repair in an In Vitro Alzheimer’s Disease Model: A Network-Transcriptomic Analysis

  2024cites this paper
• Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases

  2024cites this paper
• Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health

  2024cites this paper
• Molecular mechanisms of sulforaphane in Alzheimer’s disease: insights from an in-silico study

  2024influential citation
• The role of isothiocyanate-rich plants and supplements in neuropsychiatric disorders: a review and update

  2024cites this paper
• The Nrf2-HO-1 system and inflammaging

  2024cites this paper
• Neuroprotective Effects of Sulforaphane in a Rat Model of Alzheimer's Disease Induced by Aβ (1-42) Peptides.

  2024cites this paper
• Zebrafish models for studying cognitive enhancers.

  2024cites this paper
• Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane

  2024cites this paper
• Possible Prophylactic Effects of Sulforaphane on LPS-Induced Recognition Memory Impairment Mediated by Regulating Oxidative Stress and Neuroinflammatory Proteins in the Prefrontal Cortex Region of the Brain

  2024cites this paper
• A Comparative Review of Key Isothiocyanates and Their Health Benefits

  2024cites this paper
• Enhancement of lysosome biogenesis as a potential therapeutic approach for neurodegenerative diseases

  2023cites this paper
• Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease

  2023cites this paper
• Neurotherapeutic efficacy of loaded sulforaphane on iron oxide nanoparticles against cuprizone-induced neurotoxicity: role of MMP-9 and S100β

  2023cites this paper
• Behaviour testing in two different knockout mouse strains related to chronic inflammation and oxidative stress.

  2023cites this paper
• Dietary glucosinolates derived isothiocyanates: chemical properties, metabolism and their potential in prevention of Alzheimer’s disease

  2023cites this paper
• Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective

  2023influential citation
• Role of Nrf2 in Oxidative Stress, Neuroinflammation and Autophagy in Alzheimer's Disease: Regulation of Nrf2 by Different Signaling Pathways.

  2023cites this paper
• Mitochondrial dysfunction and inflammasome activation in neurodegenerative diseases: Mechanisms and therapeutic implications.

  2023cites this paper
• Amyloid-β mediates intestinal dysfunction and enteric neurons loss in Alzheimer's disease transgenic mouse

  2023cites this paper
• Beneficial Health Effects of Glucosinolates-Derived Isothiocyanates on Cardiovascular and Neurodegenerative Diseases

  2022cites this paper
• Sulforaphane Increase Mitochondrial Biogenesis-Related Gene Expression in the Hippocampus and Suppresses Age-Related Cognitive Decline in Mice

  2022cites this paper
• Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease

  2022cites this paper
• Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease

  2022cites this paper
• Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile

  2022influential citation
• Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies

  2021cites this paper
• Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders

  2021cites this paper
• The potential role of Keap1-Nrf2 pathway in the pathogenesis of Alzheimer’s disease, type 2 diabetes, and type 2 diabetes-related Alzheimer’s disease

  2021cites this paper
• Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease

  2021influential citation
• PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?

  2021cites this paper
• Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3β Pathway in Experimental Models of Alzheimer's Disease

  2020cites this paper
• Efficacy of Sulforaphane in Neurodegenerative Diseases

  2020cites this paper
• Nrf2 Activators as Dietary Phytochemicals Against Oxidative Stress, Inflammation, and Mitochondrial Dysfunction in Autism Spectrum Disorders: A Systematic Review

  2020cites this paper
• Merging the Multi-Target Effects of Phytochemicals in Neurodegeneration: From Oxidative Stress to Protein Aggregation and Inflammation

  2020cites this paper
• Discovery of Sulforaphane as a Potent BACE1 Inhibitor Based on Kinetics and Computational Studies

  2020cites this paper
• Sulforaphane mitigates LPS-induced neuroinflammation through modulation of Cezanne/NF-κB signalling.

  2020cites this paper
• Transcription Factor NRF2 as a Promising Therapeutic Target for Alzheimer's Disease.

  2020cites this paper
• Neuroprotective effects of ZL006 in Aβ1–42-treated neuronal cells

  2020cites this paper
• Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double‐blind, placebo‐controlled, clinical multi‐centre trial

  2020cites this paper
• The role of natural products in revealing NRF2 function.

  2020cites this paper
• Recent progress in the development of small molecule Nrf2 activators: a patent review (2017-present)

  2020cites this paper
• Supraphysiologic‐dose anabolic–androgenic steroid use: A risk factor for dementia?

  2019cites this paper
• Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease

  2019cites this paper
• Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells

  2019cites this paper
• Sulforaphane - role in aging and neurodegeneration

  2019cites this paper
• Sulforaphane triggers a functional elongation of microglial process via the Akt signal.

  2019cites this paper
• Effects of sulforaphane in the central nervous system

  2019cites this paper
• The neuroprotective mechanisms and effects of sulforaphane

  2019influential citation
• CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: Implications in tauopathies

  2019cites this paper
• Crucifers and related vegetables and supplements for neurologic disorders: what is the evidence?

  2018cites this paper
• The Effect of Treadmill Running on Insulin Receptor, Oxidative Stress, and Impaired Synaptic Plasticity in the Brain of High Fat Diet-induced 3xTg-AD Mice

  2018cites this paper
• Potential E ffi cacy of Polyphenols and Isothiocyanates in the Management of Genitourinary Diseases: A Systematic Review of Preclinical and Clinical Studies

  year unknowncites this paper